Capital International Investors’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
BGI
Capital International Investors's CLLS Position: Q1 2025 in Review
Capital International Investors sold out of Cellectis (CLLS) in Q1 2025, closing a stake of 1,848,804 shares — an estimated $3.33M sold.
Capital International Investors first reported a position in CLLS in Q4 2018 and held it in 24 quarters. The position peaked at $36.2M in Q4 2020. 27 funds tracked by Wall St. Rank hold CLLS as of Q1 2025.
- Capital International Investors reported no remaining Cellectis position as of Q1 2025 after selling out during the quarter.
- Capital International Investors sold 1,848,804 Cellectis shares in Q1 2025, an estimated $3.33M.
- Capital International Investors first reported a position in Cellectis in Q4 2018 and held it in 24 quarters.
- Capital International Investors's Cellectis position peaked at $36.2M in Q4 2020.
- 27 funds tracked by Wall St. Rank held Cellectis as of Q1 2025.
Based on Capital International Investors's 13F filing for Q1 2025, filed 12 May 2025.